Document is current
Any future updates will be listed below
-
Authors
Bacharach, Jason https://orcid.org/0000-0002-7084-4327
Lee, Wendy W.
Harrison, Andrew R.
Freddo, Thomas F.
-
Funding
Funding for this research was provided by:
RVL Pharmaceuticals, Inc., an affiliate of Osmotica Pharmaceuticals plc
- License Information
-
More Information
Article History
Received: 11 February 2021
Revised: 15 March 2021
Accepted: 7 April 2021
First Online: 29 April 2021
Compliance with ethical standards
:
: JB reports speaker fees from Aerie Pharmaceuticals, Alcon, Allergan, Bausch & Lomb, Glaukos, New World Medical, and Sun Pharmaceutical Industries, Inc.; consultant fees from Aerie Pharmaceuticals, Alcon, Allergan, Bausch & Lomb, Injectsense, New World Medical, Optovue, and Osmotica Pharmaceuticals; personal fees from Sun Pharmaceutical Industries, Inc.; and research support from Aerie Pharmaceuticals, Allergan, Novartis, Glaukos, Optovue, and Ocular Therapeutix. WWL reports consultant fees from Allergan, Galderma, Horizon Pharmaceuticals, Mallinckrodt, Osmotica Pharmaceuticals, Revance, and Solta. ARH reports consultant fees from Osmotica Pharmaceuticals and Horizon Pharmaceuticals; and speaker fees from Horizon Pharmaceuticals. TFF reports consultant fees from Osmotica Pharmaceuticals.
